The Centre is a significant investment by the firm and a key enabler of our strategy to develop the capabilities of the healthcare and life sciences practice in the UK and on the international stage.
(PRWEB UK) 1 May 2012
Deloitte, the business advisory firm, has launched the Deloitte UK Centre for Health Solutions – a new research hub for the healthcare and life sciences industry, led by Karen Taylor OBE, the former Director of Health Value for Money at the National Audit Office.
The Centre will provide insights for the firm’s healthcare and life sciences clients, helping Deloitte’s aim to become the market leading adviser. It will actively promote an environment that encourages and supports innovation in health solutions, driving independent and objective research analysis into the most complex industry issues; creating and publishing evidence-based insights and points of view.
Simon Hammett, UK and EMEA healthcare and life sciences leader at Deloitte, comments: “The Centre is a significant investment by the firm and a key enabler of our strategy to develop the capabilities of the healthcare and life sciences practice in the UK and on the international stage.
“The Centre will cover a broad health and life sciences agenda, from pharmaceuticals and medical innovation, healthcare management and reform, to the patient and healthcare consumer. It will contribute to both a private and public sector perspective, placing Deloitte at the forefront of industry debate.”
Rebecca George OBE, UK public sector health practice leader, adds: “At this time of great change and challenge for the NHS, the Centre will provide evidence-based analysis across organisational, regional and institutional boundaries. It will provide insight into the delivery of complex services in a fast changing environment which will help me and my teams deliver even more effective and targeted services.”
The Centre, comprising a team of researchers, led by Karen Taylor OBE, and assisted by Dr Karen Young, senior research manager, will work collaboratively with Deloitte’s industry practitioners, and the firm’s wider research teams.
Karen Taylor OBE, Deloitte UK Centre for Health Solutions research director, says: “The environment in which healthcare and life sciences operate has never been more challenging, both financially and in terms of balancing the supply of and demand for services. With significant changes afoot in the healthcare sector, there will be numerous opportunities and challenges in the sector, particularly in light of the challenging financial climate.
“Against this background, I am delighted to have the opportunity to lead such an exciting and ambitious initiative, at a pivotal and challenging time in the development of new science and innovation within the healthcare and life sciences industry.
“I am a strong advocate of action based on evidence. The Centre, aims to identify solutions that involve new business models, new incentives, and accelerated use of new technology, such as information technologies, and which shift the focus of healthcare from providers to consumers. We will focus our research to provide a balanced, evidence-based view that will present insights, identify solutions and intelligence that influences policy makers, informs our clients and, importantly, benefits the end user, the patient.”
Notes to editors:
Karen Taylor OBE
Karen Taylor OBE joins Deloitte having spent nine months working as an independent consultant, predominantly working for Marie Curie Cancer Care on mapping end of life care needs. Until January 2011, Karen had spent 13 years as the Director of Health Value for Money Audit (VFM) at the National Audit Office (NAO). During this time she published over 30 national VFM reports, all of which were the subject of an inquiry by the House of Commons’ Public Accounts Committee.
Karen is also a Non-Executive Director at Dartford and Gravesham NHS Trust where she chairs the Board’s Quality and Safety Committee. In 2002, Karen received an OBE for her work on Health VFM.
Dr Karen Young
Dr Karen Young has 15 years experience delivering high quality, evidence-based insight to pharmaceutical clients in the complex global healthcare market across a number of strategic and tactical issues, including market entry strategy, launch readiness and, pricing and market access. She joins Deloitte from IMS Health where she spent 10 years, including six years as a principal in the management consulting team, followed by three years as a director in operational roles including managing the EMEA oncology franchise.
Visit the Deloitte UK Centre for Health Solutions website for more details of forthcoming reports.
In this press release, references to Deloitte are references to Deloitte LLP, which is among the country's leading professional services firms.
Deloitte LLP is the United Kingdom member firm of Deloitte Touche Tohmatsu Limited (“DTTL”), a UK private company limited by guarantee, whose member firms are legally separate and independent entities. Please see http://www.deloitte.co.uk/about for a detailed description of the legal structure of DTTL and its member firms.
The information contained in this press release is correct at the time of going to press.
For more information, please visit http://www.deloitte.co.uk.
Member of Deloitte Touche Tohmatsu Limited.
# # #